Pelage CMO Christina Weng (L) and CEO Daniel Gil
GV backs hair loss biotech out of UCLA with PhII set for mid-2024
Pelage Pharmaceuticals, a Los Angeles-based hair loss biotech based on research out of UCLA, has reeled in a $16.75 million Series …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
